Cleared Traditional

K161027 - Cadwell AmpliScan (FDA 510(k) Clearance)

Nov 2016
Decision
210d
Days
Class 2
Risk

K161027 is an FDA 510(k) clearance for the Cadwell AmpliScan. This device is classified as a Amplitude-integrated Electroencephalograph (Class II - Special Controls, product code OMA).

Submitted by Cadwell Industries, Inc. (Kennewick, US). The FDA issued a Cleared decision on November 8, 2016, 210 days after receiving the submission on April 12, 2016.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1400. Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner)..

Submission Details

510(k) Number K161027 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2016
Decision Date November 08, 2016
Days to Decision 210 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code OMA - Amplitude-integrated Electroencephalograph
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Measure And Record Electrical Activity Of The Brain By Acquisition Of Amplitude-integrated Electroencephalograph (electroencephalograph Signals That Have Been Filtered And Displayed In A Specific Manner).